These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10083337)

  • 1. Donor antigen-independent effector mechanisms of graft rejection: a novel cell surface target of IL-2-activated natural killer cells.
    Norin AJ; Brewer RJ; Lui Q; Del Rio MJ; Burack J; Kamholz SL
    Transplant Proc; 1999; 31(1-2):787-8. PubMed ID: 10083337
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-2 activated killer cell activity is associated with the early phase of allograft rejection.
    Kamholz S; Roslin M; Mondragon M; Coons M; Tranbaugh R; Strashun A; Manjoney D; Norin A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):597-8. PubMed ID: 1990620
    [No Abstract]   [Full Text] [Related]  

  • 3. Donor-specific cytotoxic lymphocyte activity from bronchoalveolar lavage during acute canine lung allograft rejection.
    Sekine Y; Fujisawa T; Saitoh Y; Takeda T; Yoshida S; Urabe N; Baba M; Yamaguchi Y
    Eur J Cardiothorac Surg; 1997 May; 11(5):902-9. PubMed ID: 9196307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-dependent cell-mediated cytotoxicity and natural killer function in rejecting and infected lung allografts.
    Nguyen DM; Mulder DS; Shennib H
    Transplantation; 1993 Jun; 55(6):1250-6. PubMed ID: 8516810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered nonspecific lymphocyte cytotoxicity in bronchoalveolar lavage of lung transplant recipients: can it be useful in monitoring rejection or infection?
    Shennib H; Lee AG; Serrick C; Giaid A
    Transplantation; 1996 Nov; 62(9):1262-7. PubMed ID: 8932269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of immunological assays to monitor pulmonary allograft rejection.
    Cunningham AC; Kirby JA; Colquhoun IW; Flecknell PA; Ashcroft T; Dark JH
    Thorax; 1994 Feb; 49(2):151-6. PubMed ID: 8128405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of intragraft interleukin-2-activated killer cells and allospecific cytolytic T lymphocytes in rejecting lung allografts.
    Norin AJ; Kamholz SL
    Transplantation; 1989 Nov; 48(5):856-62. PubMed ID: 2530670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of bronchoalveolar cell profile in early detection of canine lung allograft rejection.
    Chang SC; Hsu HK; Lin CY
    Immunol Lett; 1991 Aug; 29(3):265-70. PubMed ID: 1769709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection.
    Dal Col RH; Zeevi A; Rabinowich H; Herlan DB; Yousem SA; Griffith BP
    Ann Thorac Surg; 1990 May; 49(5):754-8. PubMed ID: 2339932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early cellular events in the lung allograft.
    Adoumie R; Serrick C; Giaid A; Shennib H
    Ann Thorac Surg; 1992 Dec; 54(6):1071-6; discussion 1076-7. PubMed ID: 1449289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged pulmonary xenograft survival: tissue infiltration compared with infiltration in the bronchoalveolar space.
    Fraund S; Tschernig T; You XM; Mörike C; Emmendörffer A; Rittinghausen S; Pabst R; Haverich A; Steinhoff G
    Transplant Proc; 1999; 31(1-2):932-3. PubMed ID: 10083412
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat.
    Sido B; Morris PJ; Dallman M
    Transplant Proc; 1992 Dec; 24(6):2549-50. PubMed ID: 1465862
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged ischemia is associated with more pronounced rejection in the lung allograft.
    Serrick C; Giaid A; Reis A; Shennib H
    Ann Thorac Surg; 1997 Jan; 63(1):202-8. PubMed ID: 8993266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
    Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplantation in the rat: cellular mechanisms of allograft rejection.
    Pepper JR; Parfett GJ; Reader JA; Kirby JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):470-2. PubMed ID: 2650180
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung transplantation in the rat: a model for study of the cellular mechanisms of allograft rejection.
    Kirby JA; Parfett GJ; Reader JA; Pepper JR
    Immunology; 1988 Mar; 63(3):369-72. PubMed ID: 3280473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation with enzyme-linked immunosorbent assay spot detection of the frequency of interferon-gamma-producing T cells in bronchoalveolar lavage is useful in identifying lung transplant patients at higher risk of acute rejection.
    Meloni F; Paschetto E; Cascina A; Marone Bianco A; Pellegrini C; Oggionni T; Vitulo P; Viganò M
    Transplant Proc; 2001; 33(7-8):3286-8. PubMed ID: 11750407
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of natural killer and killer cells in concordant xenograft rejection.
    Patselas T; Thomas F; Araneda D; Marchman W
    Transplant Proc; 1995 Feb; 27(1):262-3. PubMed ID: 7878995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of TCR alpha beta+ and TCR gamma delta+ lymphocytes in bronchoalveolar lavage from human lung transplant recipients.
    Whitehead BF; Stoehr C; Finkle C; Patterson G; Theodore J; Clayberger C; Starnes VA
    Transplantation; 1993 Oct; 56(4):1031-4. PubMed ID: 8212186
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine.
    Iacono A; Dauber J; Keenan R; Spichty K; Cai J; Grgurich W; Burckart G; Smaldone G; Pham S; Ohori NP; Yousem S; Williams P; Griffith B; Zeevi A
    Transplantation; 1997 Jul; 64(2):263-9. PubMed ID: 9256185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.